• Neon Therapeutics and Apexigen Announce First Patient Dosed in Neon’s NT-003 Phase 1b Combination Trial of NEO-PV-01 in Metastatic... marketscreener.com Mon, 14 Apr 2025 17:57:43 GMT
• metastatic melanoma clinical trials and studies 2025: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Fri, 11 Apr 2025 00:02:00 GMT
• ratio chart of u.s. dollar index against 10y u.s. notes is pointing much lower The Globe and Mail Thu, 06 Mar 2025 03:02:49 GMT
• ratio chart of u.s. dollar index against 10y u.s. notes is pointing much lower The Globe and Mail Wed, 05 Mar 2025 08:00:00 GMT
• soft tissue sarcoma market poised for significant growth from openPR Tue, 21 Jan 2025 18:48:00 GMT
• esophageal cancer pipeline assessment 2024: therapies, clinical trials, latest fda, ema, and pmda approvals, clinical trials, and ... The Globe and Mail Thu, 16 Jan 2025 23:30:27 GMT
• aurora innovation inc cl a (aur-q) quote - press release The Globe and Mail Thu, 09 Jan 2025 13:07:30 GMT
• Pyxis' shares tumble after early ADC readout in solid tumors fails to spark inspiration: analyst Fierce Biotech Thu, 21 Nov 2024 08:00:00 GMT
• aligos therapeutics appoints david perry as vice president of business development StockTitan Tue, 01 Oct 2024 07:00:00 GMT
• are medical stocks lagging apexigen, inc. (apgn) this year? Yahoo New Zealand News Fri, 28 Jun 2024 03:11:15 GMT
• intratumoral cancer therapies market report 2034: epidemiology d WICZ Sun, 09 Jun 2024 07:00:00 GMT
• neurofibrosarcoma market is expected to expand at a healthy growth rate during the forecast period | ascentage ... Barchart Mon, 20 May 2024 22:28:00 GMT
• brookline capital (bcac) shareholders approve apexigen deal｜spacinsider SPACInsider Sat, 18 May 2024 22:30:22 GMT
• pancreatic cancer diagnosis market 2024 key insights | f hoffmann-la roche ag, merck kgaa, apexigen Motions Online Tue, 07 May 2024 14:48:31 GMT
• apexigen (apgn) to get acquired by pyxis oncology, stock up Yahoo New Zealand News Sun, 05 May 2024 03:54:39 GMT
• pyxis oncology obtains $8m payment for the sale of royalty rights - tipranks.com TipRanks Thu, 28 Mar 2024 11:42:20 GMT
• pyxis oncology obtains $8 million payment for the sale of royalty rights GlobeNewswire Wed, 27 Mar 2024 07:00:00 GMT
• pancreatic cancer diagnosis market [2024-2031] | f hoffmann-la roche ag, merck kgaa, apexigen Amoré Tue, 19 Mar 2024 11:10:25 GMT
• pancreatic cancer diagnosis market 2024 key insights | f hoffmann-la roche ag, merck kgaa, apexigen Amoré Wed, 13 Mar 2024 08:18:41 GMT
• intra-tumoral cancer therapies market is expected to expand at a healthy growth rate during the forecast period ... 매일세종 Fri, 01 Mar 2024 09:39:11 GMT
• synovial sarcoma market to accelerate substantially during the ... GlobeNewswire Tue, 05 Dec 2023 18:00:44 GMT
• metastatic melanoma pipeline and clinical trials assessment 2023: fda approvals, therapies and key companies i openPR Tue, 05 Dec 2023 17:23:00 GMT
• soft tissue sarcoma pipeline, fda approvals, clinical trials ... Digital Journal Mon, 04 Dec 2023 22:16:25 GMT
• intratumoral cancer therapies market to observe stupendous GlobeNewswire Wed, 15 Nov 2023 08:00:00 GMT
• oncogenic drivers and therapeutic vulnerabilities in kras wild ... Cancer Discovery Tue, 14 Nov 2023 08:26:27 GMT
• safety, efficacy, and biomarker analyses of dostarlimab in patients ... Cancer Discovery Tue, 14 Nov 2023 08:26:25 GMT
• To pave a longer runway, Pyxis to cut staff, reprioritize and offload brand-new Apexigen assets Fierce Biotech Wed, 08 Nov 2023 08:00:00 GMT
• pyxis oncology lays off 20 employees; xencor’s royalty sale to a pension plan; jazz partners with md anderson Endpoints News Wed, 08 Nov 2023 08:00:00 GMT
• hoping to pave a longer runway, pyxis cuts staff, reprioritizes Fierce Biotech Wed, 08 Nov 2023 08:00:00 GMT
• pyxis cuts staff by 40% and pours resources into two cancer therapies Pharmaceutical Technology Wed, 08 Nov 2023 08:00:00 GMT
• pyxis oncology lays off 20 employees; xencor's royalty sale to a ... Endpoints News Wed, 08 Nov 2023 08:00:00 GMT
• how apexigen inc. is revolutionizing cancer treatment Clayton County Register Tue, 31 Oct 2023 05:20:50 GMT
• biomarker testing is helping doctors find precision treatments for ... GSK Tue, 03 Oct 2023 07:00:00 GMT
• tiragolumab alone or with atezolizumab in patients with advanced ... JAMA Network Thu, 28 Sep 2023 07:00:00 GMT
• pyxis oncology announces four abstracts accepted for poster ... Yahoo Finance Wed, 27 Sep 2023 07:00:00 GMT
• flashback foreword: prognostic factors in osteosarcoma | journal ... ASCO Journals Fri, 15 Sep 2023 07:00:00 GMT
• herthena-lung01, a phase ii trial of patritumab deruxtecan ... ASCO Journals Sun, 10 Sep 2023 07:00:00 GMT
• pyxis oncology: catalysts ahead, cash in hand and an acquisition completed Seeking Alpha Thu, 07 Sep 2023 07:00:00 GMT
• oral selinexor as maintenance therapy after first-line ... ASCO Journals Tue, 05 Sep 2023 07:00:00 GMT
• bempegaldesleukin plus nivolumab in untreated advanced ... ASCO Journals Thu, 31 Aug 2023 07:00:00 GMT
• pyxis oncology successfully completes acquisition of apexigen Yahoo Finance Wed, 23 Aug 2023 07:00:00 GMT
• a phase ii trial of the cd40 agonistic antibody sotigalimab ... Cancer Discovery Tue, 22 Aug 2023 15:01:19 GMT
• pyxis oncology reports financial results for second-quarter 2023 and provides corporate update Yahoo Finance Fri, 11 Aug 2023 07:00:00 GMT
• pipeline moves: advancement prospects plunge for oesophageal ... Clinical Trials Arena Mon, 07 Aug 2023 07:00:00 GMT
• acute myeloid leukemia market size and share to rise by 2032, predicts delveinsight | key companies - chimerix, glycomimetics, aro... Yahoo Finance Mon, 07 Aug 2023 07:00:00 GMT
• mesothelin-targeting t cell receptor fusion construct cell therapy in ... Nature.com Thu, 27 Jul 2023 07:00:00 GMT
• chenghe acquisition merging with taiwan color optics in $380m deal DealFlow's SPAC News Fri, 21 Jul 2023 07:00:00 GMT
• phase ii study of olaparib and temozolomide for advanced uterine ... ASCO Journals Wed, 19 Jul 2023 07:00:00 GMT
• il-7r licenses a population of epigenetically poised memory cd8+ ... pnas.org Tue, 18 Jul 2023 13:20:58 GMT
• il-7r licenses a population of epigenetically poised memory cd8+ ... pnas.org Mon, 17 Jul 2023 07:00:00 GMT
• first-in-human, phase i dose-escalation and dose-expansion ... ASCO Journals Fri, 16 Jun 2023 07:00:00 GMT
• flashback foreword: kras is a selection marker for ... ASCO Journals Wed, 14 Jun 2023 07:00:00 GMT
• phase ii, open-label study of encorafenib plus binimetinib in ... ASCO Journals Sun, 04 Jun 2023 07:00:00 GMT
• neoadjuvant chemo flops versus upfront surgery for resectable ... Medpage Today Sun, 04 Jun 2023 07:00:00 GMT
• novel anti-her2 drugs 'impressive' in advanced biliary cancer Medpage Today Sun, 04 Jun 2023 07:00:00 GMT
• apexigen investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and pro... Business Wire Tue, 30 May 2023 07:00:00 GMT
• digital health news, funding round up in the prior week; may 30, 2023 VatorNews Tue, 30 May 2023 07:00:00 GMT
• moore kuehn encourages cwbr, rxdx, ruth, and apgn investors to contact law firm GlobeNewswire Thu, 25 May 2023 07:00:00 GMT
• pyxis oncology signs agreement to buy apexigen Pharmaceutical Technology Thu, 25 May 2023 07:00:00 GMT
• apexigen (apgn) to get acquired by pyxis oncology, stock up Yahoo New Zealand News Thu, 25 May 2023 07:00:00 GMT
• apexigen (apgn) to be acquired by pyxis oncology (pyxs) at $0.64 per share｜spacinsider SPACInsider Thu, 25 May 2023 07:00:00 GMT
• From megaround to $16M buyout: Apexigen limps to exit, accepting Pyxis' bid 300 days after going public Fierce Biotech Wed, 24 May 2023 07:00:00 GMT
• wilson sonsini advises apexigen on acquisition by pyxis oncology Wilson Sonsini Wed, 24 May 2023 07:00:00 GMT
• small spac biotech apexigen to be acquired pyxis oncology for $16m Yahoo Finance Wed, 24 May 2023 07:00:00 GMT
• apexigen stock rises on all-stock acquisition by pyxis oncology Seeking Alpha Wed, 24 May 2023 07:00:00 GMT
• today's biggest pre-market stock movers: 10 top gainers and ... InvestorPlace Wed, 24 May 2023 07:00:00 GMT
• fierce biotech m&a tracker 2023: boehringer buys t3 ... FierceBiotech Wed, 17 May 2023 10:06:33 GMT
• safety and activity of immune checkpoint inhibitors in people living ... ASCO Journals Tue, 16 May 2023 07:00:00 GMT
• checkpoint inhibitors poised to change standard of care in ... The ASCO Post Tue, 25 Apr 2023 07:00:00 GMT
• financial toxicity in cancer care: implications for clinical care and ... ASCO Journals Tue, 18 Apr 2023 07:00:00 GMT
• philly-based vintabio, gene therapy-focused cdmo, comes out ... BioBuzz Thu, 13 Apr 2023 07:00:00 GMT
• ruby trial dostarlimab plus carboplatin and paclitaxel in ... The ASCO Post Tue, 28 Mar 2023 07:00:00 GMT
• dostarlimab plus chemo deemed new standard care for ... Cancer Therapy Advisor Tue, 28 Mar 2023 07:00:00 GMT
• is apexigen, inc. (apgn) stock outpacing its medical peers this year? Yahoo Finance Australia Mon, 20 Mar 2023 07:00:00 GMT
• a single-arm phase ii trial of sitravatinib in advanced well ... Cancer Discovery Tue, 14 Mar 2023 08:29:24 GMT
• StockWatch: Pfizer Scales Patent Cliff by Pursuing Seagen Deal Genetic Engineering and Biotechnology News Thu, 02 Mar 2023 08:00:00 GMT
• sidley represents keymed biosciences in us$1.1 billion ... Sidley Austin LLP Thu, 02 Mar 2023 08:00:00 GMT
• prime® online activity - integrating the latest evidence to ... PRIME Education Tue, 28 Feb 2023 19:05:35 GMT
• months after going public, apexigen lays off 55% of staff and considers exit routes Fierce Biotech Mon, 27 Feb 2023 08:00:00 GMT
• apexigen stock plummets on review of strategic alternatives, 55% workforce reduction Seeking Alpha Mon, 27 Feb 2023 08:00:00 GMT
• chutes & ladders—john reed jumps sanofi ship, boards j&j team FierceBiotech Fri, 17 Feb 2023 08:00:00 GMT
• ppf group | fda approves checkpoint therapy imfinzi for metastatic nsclc PPF Group Tue, 31 Jan 2023 08:00:00 GMT
• 4 penny stocks to buy according to analysts & targets over 600% Penny Stocks Wed, 25 Jan 2023 08:00:00 GMT
• a first-in-human phase i study of milademetan, an mdm2 inhibitor ... ASCO Journals Fri, 20 Jan 2023 08:00:00 GMT
• 4 penny stocks to buy according to analysts & targets up to 347% Penny Stocks Thu, 19 Jan 2023 08:00:00 GMT
• apexigen touts new positive sotigalimab data showing expanded anti-tumor responses Yahoo Finance Thu, 19 Jan 2023 08:00:00 GMT
• u.s. shares mixed at close of trade; dow jones industrial average down 0.34% by investing.com Investing.com Australia Tue, 10 Jan 2023 08:00:00 GMT
• fierce biotech layoff tracker 2023: gilead's kite cuts 7% in refocus ... FierceBiotech Mon, 09 Jan 2023 19:24:18 GMT
• Apexigen Stock Soars After Analyst Rating, Is It Time to Buy? Entrepreneur Mon, 09 Jan 2023 08:00:00 GMT
• apexigen (apgn) stock jumped 126.8% on positive stock rating AskTraders.com Mon, 09 Jan 2023 08:00:00 GMT
• the $2.6 billion reason duck creek (dct) stock is soaring today InvestorPlace Mon, 09 Jan 2023 08:00:00 GMT
• mismatch repair and microsatellite instability testing for immune ... ASCO Journals Thu, 05 Jan 2023 08:00:00 GMT
• viatris announces appointments of scott a. smith and elisha w ... Viatris Thu, 29 Dec 2022 08:00:00 GMT
• niraparib in platinum-sensitive recurrent ovarian cancer (nora) OncologyPRO Thu, 15 Dec 2022 08:00:00 GMT
• prime® online activity - practical approaches to integrating ... PRIME Education Fri, 09 Dec 2022 08:00:00 GMT
• brookline capital (bcac) shareholders approve apexigen deal ... SPACInsider Mon, 21 Nov 2022 13:04:23 GMT
• phase ia/b, open-label, multicenter study of azd4635 (an ... Cancer Discovery Mon, 14 Nov 2022 08:29:08 GMT
• apexigen, inc. reports earnings results for the third quarter and nine months ended september 30, 2022 Marketscreener.com Mon, 14 Nov 2022 08:00:00 GMT
• nov. 11 quick takes: fda approves imfinzi for metastatic nsclc BioCentury Sat, 12 Nov 2022 08:00:00 GMT
• durvalumab with or without tremelimumab in combination with ... ASCO Journals Thu, 03 Nov 2022 07:00:00 GMT
• randomized study of temozolomide or temozolomide and ... ASCO Journals Wed, 19 Oct 2022 07:00:00 GMT
• Only 5 Bay Area companies went public in Q3 — and 1 moved to Texas The Business Journals Mon, 17 Oct 2022 07:00:00 GMT
• treatment of metastatic colorectal cancer: asco guideline ... ASCO Journals Mon, 17 Oct 2022 07:00:00 GMT
• esophageal cancer clinical trial pipeline insights featuring 80+ ... PR Newswire Tue, 11 Oct 2022 07:00:00 GMT
• combination dabrafenib and trametinib versus combination ... ASCO Journals Tue, 27 Sep 2022 07:00:00 GMT
• ripretinib and the failure to advance gi stromal tumor therapy in ... ASCO Journals Fri, 02 Sep 2022 07:00:00 GMT
• rich insights into the robust metastatic melanoma clinical trials ... GlobeNewswire Thu, 18 Aug 2022 07:00:00 GMT
• is apexigen (nasdaq:apgn) in a good position to deliver on growth plans? Yahoo Finance Mon, 08 Aug 2022 07:00:00 GMT
• apexigen completes business combination to become a publicly listed immuno-oncology company Yahoo Finance Mon, 01 Aug 2022 07:00:00 GMT
• phase ii study of enzalutamide for patients with androgen receptor ... ASCO Journals Fri, 22 Jul 2022 07:00:00 GMT
• apexigen and brookline capital acquisition corp. announce effectiveness of registration statement and annual stockholder meeting t... The Globe and Mail Mon, 18 Jul 2022 07:00:00 GMT
• hopeful results for chemo immunotherapy mix for pancreatic cancer Penn Medicine Sat, 04 Jun 2022 07:00:00 GMT
• promising results for chemo immunotherapy combination against ... Penn Medicine Sat, 04 Jun 2022 07:00:00 GMT
• Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from ... Nature Fri, 03 Jun 2022 07:00:00 GMT
• beyond immunotherapy: new targeted agents for advanced nsclc The ASCO Post Wed, 25 May 2022 07:00:00 GMT
• increasing racial and ethnic diversity in cancer clinical trials: an ... ASCO Journals Thu, 19 May 2022 07:00:00 GMT
• phase ii study of nivolumab and salvage nivolumab/ipilimumab in ... ASCO Journals Wed, 20 Apr 2022 07:00:00 GMT
• selinexor in advanced, metastatic dedifferentiated liposarcoma: a ... ASCO Journals Fri, 08 Apr 2022 07:00:00 GMT
• epidermal growth factor receptor inhibition in epidermal growth ... ASCO Journals Tue, 29 Mar 2022 07:00:00 GMT
• The Funded: GM is consolidating its control of Cruise via its $2.1B to buyout of SoftBank The Business Journals Mon, 21 Mar 2022 07:00:00 GMT
• these 11 bay area companies plan to go public via spac mergers — despite increasing skepticism from wall street The Business Journals Mon, 21 Mar 2022 07:00:00 GMT
• apexigen signs business combination agreement with brookline capital Pharmaceutical Technology Mon, 21 Mar 2022 07:00:00 GMT
• after megaround, apexigen inks modest spac deal to advance melanoma prospect toward approval Fierce Biotech Fri, 18 Mar 2022 07:00:00 GMT
• wilson sonsini advises apexigen on business combination agreement with brookline capital acquisition corp. Wilson Sonsini Fri, 18 Mar 2022 07:00:00 GMT
• cancer focused apexigen to go public via deal with spac brookline capital Seeking Alpha Fri, 18 Mar 2022 07:00:00 GMT
• sorrento’s scilex, apexigen opt for spac deals despite market trends BioWorld Online Fri, 18 Mar 2022 07:00:00 GMT
• sorrento's scilex, apexigen opt for spac deals despite market trends BioWorld Online Fri, 18 Mar 2022 07:00:00 GMT
• apexigen tests the market's appetite for cd40 agonism Evaluate Pharma Fri, 18 Mar 2022 07:00:00 GMT
• apexigen and brookline capital acquisition corp. announce ... GlobeNewswire Fri, 18 Mar 2022 07:00:00 GMT
• a phase 1a/b open-label, dose-escalation study of etigilimab ... Cancer Discovery Thu, 03 Mar 2022 08:23:59 GMT
• expert clinical developer dr. ovid trifan and veteran drug hunter ... PR Newswire Wed, 23 Feb 2022 08:00:00 GMT
• first-in-human phase i/ib dose-finding study of adagrasib ... ASCO Journals Tue, 15 Feb 2022 08:00:00 GMT
• clinical models to define response and survival with anti–pd-1 ... ASCO Journals Thu, 10 Feb 2022 08:00:00 GMT
• asco-gi 2022 – seagen keeps the faith in souped-up cd40 agonism Evaluate Pharma Wed, 19 Jan 2022 08:00:00 GMT
• aclaris' experimental rheumatoid arthritis drug bolsters chemo in ... FierceBiotech Wed, 01 Dec 2021 08:00:00 GMT
• immunotherapy first wins in advanced braf-positive melanoma Medpage Today Mon, 15 Nov 2021 08:00:00 GMT
• yale cancer center study shows new immunotherapy drug ... Yale School of Medicine Tue, 09 Nov 2021 08:00:00 GMT
• Once-failed cancer drug from BioXcel ramps up immunotherapy in mouse models of pancreatic cancer Fierce Biotech Mon, 08 Nov 2021 08:00:00 GMT
• getting to know eva von mühlenen: our latest digital health ... Sidley Austin LLP Mon, 01 Nov 2021 07:00:00 GMT
• pyxis oncology stock (nasdaq:pyxs), quotes and news summary Benzinga Fri, 08 Oct 2021 02:41:27 GMT
• FDA Grants Orphan Drug Designation to Sotigalimab for Soft Tissue Sarcoma OncLive Thu, 05 Aug 2021 07:00:00 GMT
• phase ii randomized study of cmb305 and atezolizumab ... ASCO Journals Wed, 14 Jul 2021 07:00:00 GMT
• chutes & ladders—trexbio snags new ceo from lilly as it prowls ... FierceBiotech Fri, 25 Jun 2021 07:00:00 GMT
• TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment... Business Wire Tue, 22 Jun 2021 07:00:00 GMT
• TRexBio has Jurassic day picking up ex-Lilly VP as CEO, snagging Big Pharma funding Fierce Biotech Tue, 22 Jun 2021 07:00:00 GMT
• trexbio chomps down on $59 million series a for immunobiology BioSpace Tue, 22 Jun 2021 07:00:00 GMT
• apexigen completes $123 million series c financing to advance clinical pipeline PR Newswire Tue, 24 Mar 2020 07:00:00 GMT
• an immuno-oncology triplet from roche shows promise in mouse models of several tumors Fierce Biotech Thu, 02 Jan 2020 08:00:00 GMT
• another immuno-oncology mechanism threatens to disappoint Evaluate Pharma Wed, 31 Jul 2019 07:00:00 GMT
• AACR: Little Apexigen steals the show with their CD40/Opdivo cocktail as AACR gets underway Endpoints News Mon, 01 Apr 2019 07:00:00 GMT
• AACR: Apexigen, BMS steal the show with promising I-O combo in pancreatic cancer Fierce Biotech Mon, 01 Apr 2019 07:00:00 GMT
• apexigen announces new clinical data on apx005m in combination therapy for pancreatic cancer at the aacr annual meeting 2019 PR Newswire Sun, 31 Mar 2019 07:00:00 GMT
• neon therapeutics and apexigen announce first patient dosed GlobeNewswire Thu, 06 Dec 2018 08:00:00 GMT
• quick-fire fundraisings give apexigen $73m for i-o push Fierce Biotech Wed, 08 Aug 2018 07:00:00 GMT
• tapping chinese investors, apexigen closes $73m for 8 trials in i/o Endpoints News Wed, 08 Aug 2018 07:00:00 GMT
• Apexigen, BMS to combine CD40 and anti-CSF-1 drugs with Opdivo in new study Fierce Biotech Thu, 14 Jun 2018 07:00:00 GMT
• chutes and ladders—lilly's oncology chief announces retirement Fierce Biotech Fri, 25 May 2018 07:00:00 GMT
• bms in vivo study director joins apexigen to lead antibody discovery FierceBiotech Fri, 18 May 2018 07:00:00 GMT
• The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Canc... PR Newswire Wed, 20 Sep 2017 07:00:00 GMT
• bms links with apexigen to test cancer immunotherapy combo PharmaTimes Thu, 13 Apr 2017 07:00:00 GMT
• 3sbio invests $10m in venture with sorrento china unit on car-t therapies FiercePharma Wed, 08 Jun 2016 07:00:00 GMT
• apexigen and shanghai duyiwei biotechnology co. ltd sign a license and collaboration agreement to develop and DNA India Tue, 19 Nov 2013 08:00:00 GMT
• china biotech in review: fundings for china-affiliated drug companies Seeking Alpha Sun, 11 Aug 2013 07:00:00 GMT
• apexigen raises $20m for cd40-targeting immunotherapy Citeline News & Insights Wed, 07 Aug 2013 07:00:00 GMT
• simcere to begin clinical trials on vegf inhibitor Asian Scientist Magazine Mon, 26 Nov 2012 08:00:00 GMT
• gsdb licenses apexigen’s humanized vegf2 mab in china Genetic Engineering & Biotechnology News Wed, 07 Mar 2012 08:00:00 GMT
• apexigen to use rabbit platform to identify mabs against centocor targets Genetic Engineering & Biotechnology News Tue, 07 Dec 2010 08:00:00 GMT
Apexigen, Inc.(NASDAQ:APGN) 
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as mela...
Website: https://www.apexigen.com
Founded: 2010
IPO Price: $10 (Jul 29, 2022)
Full Time Employees: 22
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends